| |
|
|
|
|
|
|
|||
|
Blood, 3 September 2009, Vol. 114, No. 10, pp. 2097-2106. Prepublished online as a Blood First Edition Paper on April 16, 2009; DOI 10.1182/blood-2009-01-197947.
HEMATOPOIESIS AND STEM CELLS c-Myc–mediated control of cell fate in megakaryocyte-erythrocyte progenitors1 Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL; 2 Department of Pathology, St Jude Children's Research Hospital, Memphis, TN; 3 Department of Biology, Loyola University Chicago, IL; and 4 Pathology Department, Loyola University Medical Center, Maywood, IL
It has been found that c-Myc protein plays a critical role in controlling self-renewal versus differentiation in hematopoietic stem cells. We report that c-Myc also controls the fate of megakaryocyte-erythrocyte progenitors through regulating the differentiation of erythroid and megakaryocytic progenitors. In addition to the significant reduction of granulocytes/macrophages and B and T lymphocytes because of the reduction of their corresponding progenitors, we found significantly increased numbers of megakaryocytic progenitors and mature megakaryocytes in bone marrow and spleens of c-Myc-knockout (c-Myc–/–) mice. Differentiation of erythrocytes was blocked at the erythroid progenitor stage. This increased megakaryocytopoiesis is a cell-intrinsic defect of c-Myc-mutant hematopoietic stem cells, as shown by transplantation studies. Furthermore, we found that c-Myc is required for polyploidy formation but not for cytoplasmic maturation of megakaryocytes. Megakaryocytes from c-Myc–/– mice are significantly smaller in size and lower in ploidy than those of control mice; however, because of the dramatic increase in megakaryocyte number, although fewer platelets are produced by each megakaryocyte, a greater than 3-fold increase in platelet number was consistently observed in c-Myc–/– mice. Thus, c-Myc–/– mice develop a syndrome of severe thrombocytosis-anemia-leukopenia because of significant increases in megakaryocytopoiesis and concomitant blockage of erythrocyte differentiation and reductions in myelolymphopoiesis.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||